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Freeze  casting  and  cryogenic  treatment  both  low  temperature  process  have  been  employed  to fab-
ricate  nanobiocomposite  hydroxyapatite  (HA)–gelatin–polyvinyl  alcohol  (PVA)  macroporous  scaffolds
from  synthesized  three  different  spherical,  rod  and  ﬁbrous  HA nanoparticles  and  composition  optimized
vis-á-vis  porosity  architecture,  content  and  compressive  strength.  A  critical  HA  morphology,  solid  load-
ing  and  liquid  nitrogen  interaction  time  have  a signiﬁcant  effect  to enhance  the  mechanical  response
of  developed  scaffolds.  Cryo-treated  40 wt.%  nanorod  HA–gelatin–PVA  scaffold  posses  interconnected
pore  structure  with  80 vol.%  porosity,  average  pore  diameter  50–200  m and highest  5.8 MPa  compres-orous scaffold
ompressive strength
ytotoxicity
929 cell
sive  strength.  Different  degree  of  the apatite  deposition  phenomenon  in  simulated  body  ﬂuid  solution  at
37 ◦C  and  pH ∼  7.4  varies  with  respect  to  time.  In  vitro  cytotoxicity  and  L929  mouse  ﬁbroblast  cell  culture
in  the  presence  of  Dulbecco’s  Modiﬁed  Eagle  Medium  and  10%  Fetal  Bovine  Serum  at  37 ◦C  and  5%  CO2
atmosphere  exhibit  excellent  cytocompatibility  and  cell  viability  at low extract  concentration  up to  25%.
© 2014 The  Ceramic  Society  of  Japan  and  the Korean  Ceramic  Society.  Production  and  hosting  by. Introduction
Auto graft limitation and probability of allograft induced dis-
ase transmission in recipient inﬂuence the artiﬁcial biomaterial
emand for tissue engineering [1]. As a consequence, the inter-
st has been attracted toward the use of synthetic implantable
iomaterial that reproduces the bond and morphology of natu-
al bone. Matured bone contains 65% hydroxyapatite (HA) mineral,
5–30% collagen and rest being the matrix. Cancellous bone has
igh 50–80 vol.% porosity and average pore size ∼125 m,  in which
A nanocrystals provide rigidity through insertion within colla-
en matrix, whereas high ordered ﬁbrous collagen supports the
ensile strength and ﬂexibility of bone [2]. Synthetic HA has excel-
ent protein adsorption capability and biocompatibility consist of∗ Corresponding author. Tel.: +91 661 2462207.
E-mail addresses: ds.nitrkl@gmail.com, dsarkar@nitrkl.ac.in (D. Sarkar).
eer review under responsibility of The Ceramic Society of Japan and the Korean
eramic Society.
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roduction and hosting by Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.jascer.2014.05.003Elsevier  B.V.  All  rights  reserved.
similar mineral constituent of bone and teeth [3,4]. In another end,
gelatin is a cytocompatible and biodegradable material which is
nothing but an irreversibly hydrolyzed form of collagen and has
similar chemical composition, easy availability and low cost. In
addition, gelatin has several clinical utility factors such as tempo-
rary defect ﬁller and wood dressing [5]. Polymeric binder polyvinyl
alcohol (PVA) is a biocompatible, biodegradable, highly water sol-
uble and chemical resistance material most widely employed for
biomedical application [6]. Thus, HA–gelatin–PVA nanobiocompos-
ite has great potential to consider for the selection of suitable
artiﬁcial biomaterial to mimic  the nature cancellous bone com-
position. This class of macroporous HA scaffold has extensive use
to repair and in the reconstruction of the musculoskeletal system
because of their excellent bioactivity and biocompatibility with
natural bone. High surface area, suitable pore size and intercon-
nectivity simulate the human bone structure for the migration
and cell proliferation, vascularization and as a support material for
growth of new bone [7,8]. In order to produce highly porous and
mechanically robust bioceramics, different approaches are consid-
ered such as gel casting, freeze casting, foaming, incorporation of
pore formers, dual phase mixing and salt leaching [9–12]. Freeze
casting has attracted much more attention among other methods
since solvent water itself acts as porogen to avoid the use of other
organic pore formers. Low temperature comprises fabrication of
identical bone as nanobiocomposite matrix made of HA and colla-
gen, which can minimize the several fabrication steps compared
to other processes including high temperature assisted porogen
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limination. The detailed process and advantages over formation
f porous architecture are found elsewhere [13]. Heinemann et al.
repared HA-collagen nanobiocomposite scaffold through freeze
rying technique to mimic  the cancellous bone structure, which
xhibits 85 vol.% porosity, pore size in the range of 100–200 m and
0.085 MPa  compressive strength [14]. In another study, Kane and
oeder [15] have also employed a similar technique to fabricate
A-collagen scaffold with 30 wt.% HA solid loading and achieved
.02 MPa  compressive strength when scaffold has 90 vol.% poros-
ty and 50 m elongated pore. However, the morphological effect
f different HA nanoparticles on the mechanical response, porosity
nd bioactivity of freeze casted scaffold are not well documented
o justify the efﬁcacy of HA nanoparticles for the fabrication of
caffolds. In a recent attempt, an optimized freeze casted scaf-
old has been further cryo-treated to enhance the mechanical
roperties and considered for biological assessment [13]. Hulbert
t al. [16] have demonstrated the inﬂuence of pore size on bone
egeneration, where pore size less than 10 m inhibits cellular in-
rowth, while pore between 15 and 50 m helps ﬁbro-vascular
olonization, pores between 50 and 150 m determines osteoid
rowth and pores higher than 150 m facilitates internal regen-
ration of mineralized bone. In vitro bioactivity has been assessed
hrough the spherical apatite nucleation on the surface of macro-
orous HA scaffold in simulated body ﬂuid (SBF) solution [9].
im et al. [17] investigated the in vitro cytocompatibility through
steoblastic cells (MG63), under dynamic cell culture conditions.
he differentiation and proliferation of the bone cells are mea-
ured to be a higher degree on the gelatin–HA nanocomposite
caffold compared to the pure HA scaffold. In another study Li
t al. [18] also evaluated the cytotoxicity and cell viability on freeze
asted nanoHA–chitosan composite scaffold through L929 mouse
broblast cell line. The developed composite scaffold shows non-
oxicity behavior to the L929 cells after 24 h incubation [18]. In
his perspective, the efﬁciency of optimized cryo-treated nanorod
A–gelatin–PVA macroporous scaffold has been evaluated through
ioactivity in SBF solution, in vitro cytotoxicity and cell viability for
he future scope of clinical application.
. Experimental
.1. Synthesis and characterization of HA nanoparticles
Three different HA nanoparticles prepared from common
recursors (CH3COO)2Ca and KH2PO4. Both the solutions were
repared in deionized (DI) water and slowly added into 1 L DI
ater with adjustment of solution pH and temperature. NH4OH
nd tris-buffer (tri-methylhydroxy aminomethane) solutions were
sed to maintain the solution pH for spherical and rod morphology,
espectively. Spherical HA nanoparticles (NHS), rod HA nanoparti-
les (NHR) and ﬁbroid HA nanoparticles (NHF) were prepared at
H 12.25 and temperature = 298 K, pH 9.5 and temperature = 303 K,
nd pH 5.25 and temperature = 353 K, respectively. Detailed pow-
er preparation procedure could be found elsewhere [19]. Phase
valuation of HA nanoparticles was studied through room tem-
erature powder X-ray diffraction, XRD (Philips PAN Analytical,
etherlands) with ﬁltered 1.540 A˚ Cu K- radiation. Samples were
canned in a continuous mode with a scanning rate of 0.02◦/s.
A peaks were recognized by referring JCPDS ﬁle number 74-
565. Morphologies of synthesized HA nanoparticles were studied
hrough transmission electron microscope (JEOL JEM-2100, TEM).
he TEM samples were prepared by dispersing a small amount of
owder in acetone using 20 kHz and 500 W ultrasonic energy for
0 min. The dispersed suspension was dropped on a carbon coated
opper grid and dried to evaporate the solvent and images wereramic Societies 2 (2014) 241–247
taken in bright ﬁeld mode. The surface area of nanoparticles was
measured through BET surface area (Quanta chrome, Autosorb-I).
2.2. Fabrication and characterization of porous scaffold
Freeze casting technique was employed to fabricate porous HA
scaffolds from three HA different morphologies such as NHS, NHR
and NHF. PVA solution was prepared in DI water (10 wt.% PVA)
at 80 ◦C by constant stirring. After the formation of a clear PVA
solution, the solution was  cooled down to 30 ◦C. Gelatin (15 wt.%)
was mixed with PVA solution and stirred for 2 h. HA nanoparticles
were slowly added into PVA–gelatin solution, and further continu-
ously stirred for homogenous mixing. The resulting HA slurry was
casted into a glass mold and pre-freezed for 12 h at −5 ◦C inside
a refrigerator, followed by freeze drying for 24 h at −53 ◦C and
77 torr. Freeze casted HA–gelatin–PVA scaffolds were designed as
HGPS, HGPR and HGPF for spherical, rod and ﬁbroid morpholo-
gies, respectively. Different grade of scaffolds was prepared with
solid loading variation of 30, 40 and 50 wt.%. Nanorod HA and
their 40 wt.% solid loading scaffold exhibited highest compressive
strength with 70 vol.% porosity and hence considered as optimized
composition to enhance the mechanical strength through cryo-
treatment at different time schedules. Optimized cryo-treatment
time was  considered for 5 h [13]. The cryo-treated macroporous
HA–gelatin–PVA scaffolds were designed as HGPS05, HGPR05 and
HGPF05 for HGPS, HGPR and HGPF scaffolds, respectively. Both as
freeze casted and cryo-treated HA–gelatin–PVA scaffold (ø-14 mm,
h-16 mm)  samples were uniaxially compressed by universal test-
ing machine (H10 KS Tinius Olsen). Elastic modulus was calculated
from the slope of the stress–strain curve. HA solid content was
optimized from mechanical response and pore size phenomena
were evaluated for the same. Surface morphology, microstructure
and pore shape of cryo-treated HA–gelatin–PVA scaffold samples
were studied through scanning electron microscope (SEM) (JEOL
JSM 6480LV). The SEM images of platinum coated samples were
observed in secondary electron mode at 20 kV. Porosity of scaffolds
were measured by applying Archimedes’ principle using ethanol
as solvent, as well as cross checked through mercury intrusion
porosimetry (Quantachrome, Pore master-33). Mercury intrusion
porosimetry was  also employed to measure pore size and distri-
bution of all scaffolds. The HA scaffold samples were placed in a
penetrometer and infused with mercury under increasing pressure
(1.0–33,000 psi) with Hg contact angle 140◦.
2.3. In vitro bioactivity of the scaffold
A similar human blood plasma ion concentration was  prepared
at 7.4 solution pH and 37 ◦C temperature from different chemi-
cals and designated as SBF solution [20]. The HGPR05 scaffolds
(0.5 g, 3 × 6 × 10 mm3) were soaked in 20 mL  of SBF solution inside
a closed polystyrene (Tarson) petridis and kept in an incubator at
temperature 37 ◦C and solution pH ∼ 7.4 for the time interval of 1,
3 and 7 days to assess in vitro bioactivity. The SBF soaked sam-
ples were repeatedly cleaned with DI water and dried at 40 ◦C for
12 h prior to understanding the bioactivity. Feasibility of the apatite
nucleation and deposition was studied through SEM attached with
EDX.
2.4. Cytotoxicity assessment of scaffold
In vitro cytotoxicity test of steam sterilized HGPR05 scaffold
was performed using mammalian mouse ﬁbroblast cell line, L929
by direct contact method as per ISO-10993-5 guideline [21]. L929
cells were used in the present study, because it can be easily cul-
tured in a reproducible manner, and also this cell line is widely
used for preliminary cytotoxicity evaluation for a wide range of
ian Ceramic Societies 2 (2014) 241–247 243
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iomaterials because of easy proliferation and adherence on most
f the biomaterial surface. In the beginning, guide line L929 cells
ere subcultured, trypsinized and seeded on to multiwall tis-
ue culture plates. The L929 ﬁbroblast cells were cultured with
ulbecco’s Modiﬁed Eagle Medium, 10% Fetal Bovine Serum and
ncubated at 37 ◦C in 5% CO2 atmosphere till formation of the cell
onolayer. The test specimen (HGPR05) was incubated with mono-
ayer cells at 37 ◦C for 24–26 h. The HGPR05 surface was examined
sing phase contrast microscope for cellular response after the req-
isite incubation. In vitro cytotoxicity of the test specimen was
ompared with the negative control (high density polyethylene),
 nontoxic material and positive control (stabilized PVA disk), a
oxic material. Cell monolayer was examined microscopically for
he response around the test specimens.
.5. Cell viability study on scaffolds
The MTT  assay was performed to measure the metabolic activ-
ty of cells and estimated through ‘color-change’ phenomenon from
ellow colored tetrazolium salt, MTT  {3-(4,5-diamethyl thiazol-2-
l)-2,5-diphenyltetrazolium bromide} to purple colored formazan.
resh test specimens (HGPR05) were sterilized by steam steriliza-
ion at 121 ◦C for 20 min  and extract was prepared after 24–26 h
ncubation at 37 ± 1 ◦C in 1 mL  culture medium with containing
erum protein. The extract solution was further diluted to 50%,
5% and 12.5% in same culture medium. Equal volume (100 L)
f extract, as obtained from HGPR05, negative control (high den-
ity polyethylene), positive control (dilute phenol) and cell were
laced on the subconﬂuent monolayer of L929 cells and incubated
or 24 ± 2 h at 37 ± 1 ◦C. The cultured cells were treated with 50 L
f MTT  and further incubated at 37 ± 1 ◦C for 4 h in humidiﬁed and
% CO2 atmosphere. The excess amount of MTT  was  removed by
spiration and 100 L of isopropanol was added in order to dissolve
he formazan crystals. Cytotoxicity tests were performed in tripli-
ate. The color exchange was quantiﬁed by measuring absorbance
t 570 nm using a spectrophotometer.
. Results and discussion
Phase content, purity and crystallinity of the synthesized HA
anoparticles are evaluated through XRD patterns and represented
n Fig. 1. XRD pattern of NHS and NHR reveals the formation of HA
ure phase with semicrystalline behavior at 25 ◦C, whereas NHF
hows high crystallinity after synthesis at relatively high 80 ◦C tem-
erature. The diffraction peaks for all HA nanoparticles conﬁrm
he hexagonal structure of HA. Low temperature synthesized HA
anoparticle appears without any secondary phase as tricalcium
hosphates. The results reveal that the crystallinity of HA phase
Fig. 2. HRTEM micrographs of synthesized HA naFig. 1. XRD pattern of synthesized HA nanoparticles (A) NHS, (B) NHR and (C) NHF.
increases along with an increase in aspect ratio and decrease with
the solution pH. Low solution pH favors anisotropic growth of cal-
cium deﬁcient ﬁbrous apatite particles, whereas high solution pH
facilitates isotropic growth of the apatite nuclei which result in
semicrystalline behavior at low temperature (25 ◦C). The calculated
crystallite size for NHS, NHR and NHF is recorded as 9 nm,  12 nm and
60 nm,  respectively. Fig. 2 shows a bright ﬁeld HRTEM micrographs
of the synthesized HA nanoparticles. NHS shows spherical mor-
phologies with ∼20 nm diameter, rod morphologies show ∼15 nm
diameters with aspect ratio ∼5, whereas ﬁbroid morphologies of
HA exhibits micron size length with 30–40 nm diameters. The mea-
sured BET speciﬁc surface area of the synthesized HA nanoparticles
are 256 m2/g, 217 m2/g and 47 m2/g for NHS, NHR and NHF and
their calculated particle size are 7, 9 and 70 nm,  respectively.
Solid loading effect of different HA nanoparticles on porosity
and compressive strength are studied and represented in Fig. 3. It
is observed that apparent porosity decreases with increase solid
loading from 30 to 50 wt.%, but compressive strength enhances for
the same scaffolds. However, both the properties follow non-linear
behavior as also demonstrated by Fritsch et al. [22]. Reasonable
compressive strength and appropriate porosity of the scaffold is the
result for 40 wt.% HA solid loading. The freeze casted HGPR scaffold
reveals an average compressive strength of ∼2 MPa  with the elastic
modulus 70 MPa. Higher compressive strength for HGPR scaffold
achieved because of moderate aspect ratio and semi-crystalline
behavior, which favors high anchoring effect throughout the gelatin
noparticles (A) NHS, (B) NHR and (C) NHF.
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folds under compression are represented in Fig. 6. The property of
the cryo-treated HA–gelatin–PVA porous scaffolds and their detail
mechanical behavior is shown in Table 1. Under identical loading
Table 1
Physical properties of cryo-treated HA–gelatin–PVA scaffold.
Sample ID Porosity (%) Compressive Elastic Pore sizeFig. 3. Variation of porosity and compressive strength fo
atrix. This optimized scaffold has been considered to enhance
echanical strength through cryo-treatment.
SEM microstructure of 5 h cryo-treated HA–gelatin scaffolds for
ptimum 40 wt.% solid loading is represented in Fig. 4. Adequate
orosity, uniform pore size and reasonable strength are the key
eatures for the selection of such a scaffold. HGPS05 scaffold results
n irregular pore morphologies with partly connected open macro-
orous structure and average pore diameter in the range ∼170 m
s illustrated in Fig. 4A. Open macroporous architecture with aver-
ge pore diameter in the range ∼160 m is observed for the HGPR05
caffold (Fig. 4B). Fig. 4C represents the SEM microstructure of
GPF05 scaffold. HGPF05 scaffold has relatively larger pore diam-
ter than the counterpart HGPR05 and HGPS05 scaffolds. Elliptical
pen macropores with average pore diameter observe in the range
180 m.  HGPR05 scaffold demonstrates well pore size distri-
ution with the reticulated open porous structure as compared
o HGPS05 and HGPF05, which is further conﬁrmed by mercury
orosimeter analysis. Most of the pores are open macroporous and
referably have irregular elliptical shape. Different pore size, con-
ent and morphologies are inﬂuenced by the HA surface area, solid
oading and PVA molecular interaction phenomena during freeze
asting process as well as cryo-treatment. Pore size distribution
fter 5 h cryo-treated scaffold is analyzed through mercury intru-
ion porosimetry, as demonstrated in Fig. 5. Mono-mode pore size
istribution is observed for HGPS05 with average pore diameter in
he range ∼90 m and some micro pores in the range ∼1–10 m
Fig. 5A). Porosity of HGPS05 scaffold is measured 80 vol.% through
ercury intrusion porosimeter. Fig. 5B exhibits multimodal pore
ize distribution for HGPR05 scaffold with average pore diameter
n the range ∼85 m,  78 vol.% porosity and micron size pores in the
ange ∼0.1–1 m.  The existence of micron size pore distribution isGPS, (B) HGPR and (C) HGPF with respect to HA  content.
attributed to the growth of tiny ice crystals while freezing process
[23]. Fig. 5C illustrates the similar pore size distribution pattern
for HGPF05 scaffold. The average pore diameter is observed in the
range of ∼100 m along with porosity of around 85 vol.%. Different
gradation of micro pore is observed in the range of ∼0.1–10 m.
Strong anchoring of HA particles in the gelatin matrix develops ice
crystals during freeze casting followed by cryo-treatment that facil-
itates diverse pore size distribution as revealed by porosimetry and
SEM microstructure. Tiny closed pores are difﬁcult to encounter
through SEM microstructure, but mercury porosimeter evaluates
all range of open and closed pores diameter (0.1–200 m) and
cumulative pore size shifted to the lower region. Multimodal pore
size along with variation in pore diameter may  suitable for the pro-
liferation of osteoblast and mesenchymal stem cell as well as the
easy passage of nutrients through the pores.
The optimum composition of HA–gelatin–PVA scaffold at liq-
uid nitrogen environment shows the higher mechanical properties
compared with the untreated HA scaffold. Stress–strain behavior of
40 wt.% solid content after 5 h cryo-treated HA–gelatin–PVA scaf-strength (MPa) modulus (MPa) (m)
HGPS05 80 ± 2 5.2 ± 0.05 185 ± 3 170 ± 4
HGPR05 75 ± 3 5.8 ± 0.08 202 ± 5 160 ± 5
HGPF05 85 ± 2 4.7 ± 0.03 167 ± 3 180 ± 3
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face as compared to the dense surface because of their high surface
area. Aforementioned data illustrate that the apatite preferentially
deposits along the macroporous architecture of the scaffold.ig. 4. SEM microstructure of scaffold (A) HGPS05, (B) HGPR05 and (C) HGPF05 for
0 wt.% solid loading.
ondition, the cryo-treated HA–gelatin–PVA scaffold exhibits 5.2,
.8 and 4.7 MPa  stress and corresponding modulus are 155, 202
nd 167 MPa  for HGPS05, HGPR05 and HGPF05 scaffold, respec-
ively. The rate of stain 5% is observed in HGPS05 and 8% in HGPR05,
hereas 12% strain is calculated in HGPF05 scaffold. Asefnejad et al.
24] demonstrated freeze casted nanoHA–polyurethane composite
as 50–200 m pore size, 80 vol.% porosity and 0.6 MPa  compres-
ive strength [24]. In another study, Isikli et al. [25] reported
orous chitosan–gelatin–HA scaffold have moderate compressive
trength ∼ 3 MPa  and such scaffold also support attachment andFig. 5. Mercury intrusion pore size distribution of HA–gelatin–PVA scaffolds (A)
HGPS05, (B) HGPR05 and (C) HGPF05 for 40 wt.% solid loading.
proliferation of bone cells. Low strain rate and high compressive
strength reveal that scaffold develops relatively ductile to brit-
tle transition. Organic polymer matrix of the scaffold under goes
ductile behavior to the brittle nature through the development of
internal stress which increases the compressive strength at the
cryogenic temperature (77 K).
In vitro bioactivity of the HGPR05 scaffolds in SBF solution is
evaluated and represented in Fig. 7. Fig. 7A illustrates the nucle-
ated spherical apatite layer on the HGPR05 scaffold surface at
37 ◦C and pH ∼ 7.4 after one day incubation. Fig. 7B represents the
SEM microstructure after 3 days incubation of HGPR05 scaffold
in SBF solution. However, minimum seven days are required for
the complete deposition of near spherical apatite particles without
existence of any bare scaffold surface as demonstrated in Fig. 7C.
The mechanism of the apatite layer formation on the HA scaffold
surface inﬂuence by the surface charge of the HA scaffold that
absorbs Ca2+ and PO43− from the metastable SBF solution and forms
amorphous apatite layer [26]. In addition, the nucleated spheri-
cal shaped apatite layer on the surface of the HA scaffold in SBF is
also conﬁrmed through EDAX. EDAX images show the presence of
prime elements such as Ca, P, O and C along with some trace ele-
ments of Mg  and Na from SBF solution. Combined SEM and EDAX
supports the bioaccessibility of such macroporous HA–gelatin–PVA
scaffolds. The deposition of apatite layer begins on the porous sur-Fig. 6. Stress–strain behavior of the 5 h cryo-treated HA–gelatin–PVA scaffolds.
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olutio
v
t
a
FFig. 7. Apatite nucleation on the HGPR05 scaffold in SBF sThe cell adhesion/proliferation, L929 mouse ﬁbroblast cells
iability on HGPR05 scaffolds is investigated using phase con-
rast microscopy and MTT  analysis, respectively. The results are
lso compared with positive control and negative control. Some
ig. 8. Phase contrast microscopic image revealing the adhesion of cultured L929 cells aftn associated with EDX (A) 1 day, (B) 3 days and (C) 7 days.representative microscopic images of cultured L929 cells are shown
in Fig. 8. The cell density on the negative control (high density
polyethylene) is very similar to the ﬁbroblast-like morphology
with cell-to-cell contacts and ﬁlopodia extension. In contrast, the
er one day of incubation: (A) negative control, (B) positive control and (C) HGPR05.
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[26] H.M. Kim, T. Himeno, T. Kokubo and T. Nakamura, Biomaterials, 26, 4366–4373
(2005).Fig. 9. MTT  assay results of various extracts of HGPR05 along with control.
929 cells are almost dead on positive control (stabilized PVC disk)
evealing severs toxicity. Similar to the negative control, the spin-
le shaped L929 cells are found to adhere and expand on HGPR05
Fig. 8C). The fraction of globular shaped is similar on both posi-
ive control and HGPR05 scaffold. The observation of the globular
haped L929 cells can be the result of the initial degradation rate
f the HGPR05 and the release of the polymeric small chains. Fig. 9
epresents MTT  assay results on the cell viability and proliferation
f L929 cells on the test material, HGPR05 at different concentra-
ions. The metabolic activity of HGPR05 extracts in contact with
929 cell is near to 40% as the developed formazan is directly pro-
ortional to the number of mitochondrially active cells [27]. Clearly,
he MTT  assay results reveal that the metabolic activity of L929
ells decreased with the increase in the extract concentration of
GPR05 in vitro, as shown in Fig. 9. As far as the quantiﬁcation of
ell viability concern, 90% of the cells are viable on the negative
ontrol and <10% cells on positive control. It is important to men-
ion that, at the HGPR05 extract concentration at 12.5% and 25%,
ore than the 70% of the cells is mitochondrially viable. Although a
igniﬁcant decrease in cell viability at 100% extract is recorded, and
ear to four times on larger cells population are mitochondrially
ctive than compared to the positive control. The slow degrada-
ion from the HGPR05 scaffold appears to cause toxicity to L929
ells at higher extract concentration up to 50% or more. The afore-
entioned study and relevant data conﬁrms the cytocompatibility
f HGPR05 with L929 ﬁbroblast cell. The cytotoxicity testing using
929 mouse ﬁbroblast cells over 24 h reveals the attachment and
roliferation of connective tissue cells on the HGPR05 scaffold in a
anner that is comparable to that on the negative control.
. ConclusionsFor the ﬁrst time we developed such a highly porous with
oderate compressive strength nanobiocomposite scaffolds. Three
ifferent morphologies have signiﬁcant inﬂuence on the com-
ressive strength; pore size and pore volume of cryogenically
[ramic Societies 2 (2014) 241–247 247
treated freeze casted HA–gelatin–PVA macroporous scaffolds.
The combination of the freeze casting and cryogenic treat-
ment HA–gelatin–PVA macroporous scaffolds develops anisotropic
pore morphology. The macroporous scaffold exhibits 80 vol.%
porosity with average pore diameter in the range ∼50–200 m.
Stress–strain behavior reveals the ductile to quasi-plastic nature
at strain of 8%. Multimodal pore size distribution with optimum
strength ∼5.8 MPa  and compression modulus ∼200 MPa  obtained
at 40 wt.% of HA solid loading. In vitro apatite preferentially deposits
around the porous architecture compared to dense matrix, how-
ever, optimum seven days incubation requires for the complete
coverage on macroporous scaffolds. In vitro cytotoxicity and cell
viability reveals excellent cytocompatibility and cell viability to
L929 cells at low extract concentration up to 25%, whereas higher
extract concentration induces slight toxic effect to L929 cells
compared to positive and negative control. The anisotropic pore
morphology, cytocompatibility and cell viability of the scaffold sug-
gest the probable use for the healing of cancellous bone and delivery
of bone growth factors.
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